Evans Daron

CEO Specialty Renal ProductsNEPHROS INC (NEPH) · full profile →Form 4/A · filed Jun 1, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 27, 2021Tax withholding(F)349$2.70$9429K
May 27, 2021Tax withholding(F)349$2.70$9429K

Transaction Codes

F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0000914190-21-000169) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.